Detalles de la búsqueda
1.
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
Proc Natl Acad Sci U S A
; 112(23): E3030-9, 2015 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26039997
2.
Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
Oncotarget
; 12(5): 519-520, 2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747364
3.
Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes.
Sci Rep
; 7(1): 10608, 2017 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28878218
4.
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
Oncotarget
; 7(7): 7816-28, 2016 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26761211
5.
VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy.
Diabetes
; 62(11): 3863-73, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23884892
Resultados
1 -
5
de 5
1
Próxima >
>>